All News

The Food and Drug Administration (FDA) approved Tagrisso as a first-line treatment for patients with non–small cell lung cancer (NSCLC) whose tumors harbor EGFR mutations.

The Food and Drug Administration (FDA) granted priority review to a supplemental biologics license application for Opdivo (nivolumab) for the treatment of patients with small cell lung cancer with disease progression following two or more lines of therapy.

After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.

Why does shame seem to go along with a cancer diagnosis, and how can we help each other?

Tavalisse (fostamatinib) was granted approval by the Food and Drug Administration (FDA) for patients with chronic immune thrombocytopenia (ITP) after they had an insufficiencent response to another therapy.

How I learned I was "no evidence of active disease," was reminded of an important appointment and the other benefits that the OpenNotes movement wants to make available to all patients

Here's my advice on all that non-expert advice.

Berubicin showed promise in the treatment of glioblastoma as a drug that was able to cross the blood-brain barrier.

Only a 20-something cancer survivor could re-imagine his port removal procedure as a deleted scene from the Avengers.

Most recently, the dynamic duo of Yervoy (ipilimumab) plus Opdivo (nivolumab) – both checkpoint inhibitors – extended average progression-free survival (PFS) rates more than three times than standard-of-care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) with high tumor mutational burden (TMB).

Connections on the cancer ward are Inevitable, but fear of loss can make those relationships painful.

Lets try positive motivation to improve our diet and exercise habits!

“Young people, in general, think they are invincible. I certainly did.” Said Stacy Hurt, an early-age onset rectal cancer survivor.

Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.

While many of us may share the same or a similar diagnosis how an individual manages a situation or feelings is individualized.

The Food and Drug Administration (FDA) approved the immunotherapy combination of Yervoy (ipilimumab) plus Opdivo (nivolumab) to treat patients with intermediate- or poor-risk advanced renal cell carcinoma in the frontline setting.

When I was a kid, my Walkman helped me through my chemotherapy treatments.

Can you believe I was invited to pay tribute to “Wonder Woman” in Baltimore last month? It’s true! I’ve never been so proud or excited. At 60 years old, that’s saying something.

We have the right and the obligation to honor our "veto vote" where our own health and healing is concerned.

If patients with colon cancer follow the previously-issued American Cancer Society guidelines on nutrition and physical activity, they can improve outcomes in to survivorship.

Waiting on a scan is sometimes the hardest part.

Breast cancer brings an unexpected type of notoriety. Read this survivor's story.

Too often, the news, internet and social media focus on the sad stories. As survivors, it is up to us to focus on those stories that are positive and how survivors living their lives. I call it the living stories.

Patients with cancer are often asked when they’ll be done with chemotherapy or treatment. Those of us with blood cancers and bone marrow type of cancers such as aplastic anemia, myelodysplastic syndrome, lymphoma and leukemia, along with a host of other cancers sadly have to say, “never.”

A new drug combination bested current standard of care in a clinical trial.

What if prayers do not cure cancer every single time? No cancer patient or survivor should feel like a moral failure. Here are some suggestions from my experience to avoid hurting others with good intentions.

When stuck in this space, it is tempting to hide from life, but with all the beauty in the world, it doesn't serve any of us to hide.

Often, it is the nurses who hold the hands of the patient who is extremely ill in critical care or dying. It is the nurses left to comfort the grieving families after the devastating loss of a loved one.